| SIRT6 is responsible for more efficient DNA double-strand break repair in long-lived species X Tian, D Firsanov, Z Zhang, Y Cheng, L Luo, G Tombline, R Tan, ... Cell 177 (3), 622-638. e22, 2019 | 290 | 2019 |
| Endometrial stromal cells and decidualized stromal cells: origins, transformation and functions H Zhu, CC Hou, LF Luo, YJ Hu, WX Yang Gene 551 (1), 1-14, 2014 | 92 | 2014 |
| Small non-coding RNAs and their associated proteins in spermatogenesis LF Luo, CC Hou, WX Yang Gene 578 (2), 141-157, 2016 | 73 | 2016 |
| Risk of cancer after diagnosis of cardiovascular disease CF Bell, X Lei, A Haas, RA Baylis, H Gao, L Luo, SH Giordano, ... Cardio Oncology 5 (4), 431-440, 2023 | 70 | 2023 |
| The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis KU Jarr, J Ye, Y Kojima, Z Ye, H Gao, S Schmid, L Luo, RA Baylis, M Lotfi, ... Nature cardiovascular research 1 (3), 253-262, 2022 | 36 | 2022 |
| Nuclear factors: roles related to mitochondrial deafness LF Luo, CC Hou, WX Yang Gene 520 (2), 79-89, 2013 | 32 | 2013 |
| Dynamic changes in chromatin accessibility are associated with the atherogenic transitioning of vascular smooth muscle cells Y Wang, H Gao, F Wang, Z Ye, M Mokry, AW Turner, J Ye, S Koplev, ... Cardiovascular research 118 (13), 2792-2804, 2022 | 29 | 2022 |
| Role of PDE10A in vascular smooth muscle cell hyperplasia and pathological vascular remodelling L Luo, Y Cai, Y Zhang, CG Hsu, VA Korshunov, X Long, PA Knight, ... Cardiovascular Research 118 (12), 2703-2717, 2022 | 13 | 2022 |
| Role of cAMP in cardiomyocyte viability: beneficial or detrimental? Y Zhang, S Chen, L Luo, S Greenly, H Shi, JJ Xu, C Yan Circulation Research 133 (11), 902-923, 2023 | 8 | 2023 |
| Identifying shared transcriptional risk patterns between atherosclerosis and cancer RA Baylis, H Gao, F Wang, CF Bell, L Luo, JLM Björkegren, NJ Leeper Iscience 26 (9), 2023 | 5 | 2023 |
| Role of vascular smooth muscle cell clonality in atherosclerosis L Luo, C Fu, CF Bell, Y Wang, NJ Leeper Frontiers in Cardiovascular Medicine 10, 1273596, 2023 | 3 | 2023 |
| Clustering cancers by shared transcriptional risk reveals novel targets for cancer therapy H Gao, RA Baylis, L Luo, Y Kojima, CF Bell, EG Ross, F Wang, NJ Leeper Molecular Cancer 21 (1), 116, 2022 | 3 | 2022 |
| The protective role of natriuretic peptide receptor 2 against high salt injury in the Renal Papilla GJ Dugbartey, B Quinn, L Luo, DM Mickelsen, SK Ture, CN Morrell, ... The American Journal of Pathology 189 (9), 1721-1731, 2019 | 3 | 2019 |
| Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis S Bamezai, Y Zhang, M Kumari, M Lotfi, T Alsaigh, L Luo, GS Kumar, ... Nature communications 15 (1), 8034, 2024 | 2 | 2024 |
| Cancer Incidence After Diagnosis of Abdominal Aortic Aneurysm L Luo, AM Haas, CF Bell, RA Baylis, SS Adkar, C Fu, I Angelov, ... Arteriosclerosis, Thrombosis, and Vascular Biology, 2024 | 2 | 2024 |
| Cardiovascular Disease and Breast Cancer Stage at Diagnosis I Angelov, AM Haas, E Brock, L Luo, J Zhao, BD Smith, SH Giordano, ... JAMA Network Open 8 (1), e2452890-e2452890, 2025 | 1 | 2025 |
| Spatial metabolomics and the vulnerable atherosclerotic plaque L Luo, NJ Leeper Arteriosclerosis, Thrombosis, and Vascular Biology 43 (9), 1636-1638, 2023 | 1 | 2023 |
| Correction to: Role of PDE10A in vascular smooth muscle cell hyperplasia and pathological vascular remodelling L Luo, Y Cai, Y Zhang, CG Hsu, VA Korshunov, X Long, PA Knight, ... Cardiovascular Research 119 (3), 879-879, 2023 | 1 | 2023 |
| Coronary artery disease and prostate cancer share a common genetic risk mediated through Lipoprotein (a) RA Baylis, F Wang, H Gao, C Bell, L Luo, KT Nead, TG Neilan, EG Ross, ... medRxiv, 2022.11. 08.22282072, 2022 | 1 | 2022 |
| Protocol for tyramide signal amplification immunohistochemical detection of Notch1 signaling in the vascular system Y Lin, S Singh, C Xu, Z Wang, C Feng, D Jiang, L Luo, W Li, W Che, ... STAR protocols 5 (4), 103519, 2024 | | 2024 |
